These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 16728729)
41. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies. Watts GF; Chan DC; Ooi EM; Nestel PJ; Beilin LJ; Barrett PH Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):877-82. PubMed ID: 16922825 [TBL] [Abstract][Full Text] [Related]
42. [The lipid metabolism of the small intestine and its correlation to the lipid and lipoprotein metabolism of the total organism]. Gangl A Acta Med Austriaca Suppl; 1975; 2():1-49. PubMed ID: 1065179 [TBL] [Abstract][Full Text] [Related]
43. Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. Parhofer KG; Barrett PH J Lipid Res; 2006 Aug; 47(8):1620-30. PubMed ID: 16720894 [TBL] [Abstract][Full Text] [Related]
44. Development of a compartmental model of human zinc metabolism: identifiability and multiple studies analyses. Miller LV; Krebs NF; Hambidge KM Am J Physiol Regul Integr Comp Physiol; 2000 Nov; 279(5):R1671-84. PubMed ID: 11049849 [TBL] [Abstract][Full Text] [Related]
45. Development of a compartmental model describing the dynamics of vitamin A metabolism in men. von Reinersdorff D; Green MH; Green JB Adv Exp Med Biol; 1998; 445():207-23. PubMed ID: 9781391 [TBL] [Abstract][Full Text] [Related]
46. A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism. Sips FL; Tiemann CA; Oosterveer MH; Groen AK; Hilbers PA; van Riel NA PLoS Comput Biol; 2014 May; 10(5):e1003579. PubMed ID: 24784354 [TBL] [Abstract][Full Text] [Related]
47. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Burnett JR; Telford DE; Barrett PH; Huff MW Biochim Biophys Acta; 2005 Dec; 1738(1-3):10-8. PubMed ID: 16427354 [TBL] [Abstract][Full Text] [Related]
48. Quantitative assessment of lipoprotein metabolism by positron emission tomography with an 18F-containing residualizing label. Daugherty A; Kilbourn MR; Dence CS; Sobel BE; Thorpe SR Int J Rad Appl Instrum B; 1992 Apr; 19(3):411-6. PubMed ID: 1629030 [TBL] [Abstract][Full Text] [Related]
49. Labeling the human skeleton with 41Ca to assess changes in bone calcium metabolism. Denk E; Hillegonds D; Vogel J; Synal A; Geppert C; Wendt K; Fattinger K; Hennessy C; Berglund M; Hurrell RF; Walczyk T Anal Bioanal Chem; 2006 Nov; 386(6):1587-602. PubMed ID: 17033771 [TBL] [Abstract][Full Text] [Related]
50. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)]. Krempler F Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345 [TBL] [Abstract][Full Text] [Related]
51. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus. Duvillard L; Pont F; Florentin E; Gambert P; Vergès B Diabetologia; 2000 Jan; 43(1):27-35. PubMed ID: 10663213 [TBL] [Abstract][Full Text] [Related]
52. A simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrations. Hopkins PN; Williams RR Am J Clin Nutr; 1981 Nov; 34(11):2560-90. PubMed ID: 7030050 [TBL] [Abstract][Full Text] [Related]
53. Modeling metabolic networks for mammalian cell systems: general considerations, modeling strategies, and available tools. Gerdtzen ZP Adv Biochem Eng Biotechnol; 2012; 127():71-108. PubMed ID: 21984615 [TBL] [Abstract][Full Text] [Related]
54. New advances in stable tracer methods to assess whole-body protein and amino acid metabolism. Engelen MPKJ; Ten Have GAM; Thaden JJ; Deutz NEP Curr Opin Clin Nutr Metab Care; 2019 Sep; 22(5):337-346. PubMed ID: 31192825 [TBL] [Abstract][Full Text] [Related]
55. Tracer kinetics and metabolic models in medicine. Junghans P; Wagner B; Nickel A; Faust H Isotopes Environ Health Stud; 2012 Jun; 48(2):226-38. PubMed ID: 22502628 [TBL] [Abstract][Full Text] [Related]
56. [Changes of lipoproteins during insulin therapy in diabetes mellitus type 1]. Pantelinac P Med Pregl; 2009; 62 Suppl 3():66-9. PubMed ID: 19702119 [TBL] [Abstract][Full Text] [Related]
57. Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are. Magkos F; Sidossis LS Curr Opin Clin Nutr Metab Care; 2004 Sep; 7(5):547-55. PubMed ID: 15295275 [TBL] [Abstract][Full Text] [Related]
58. Endogenously labeled low density lipoprotein triglyceride and apoprotein B kinetics. Malmendier C; Berman M J Lipid Res; 1978 Nov; 19(8):978-84. PubMed ID: 215686 [TBL] [Abstract][Full Text] [Related]
59. A resource facility for kinetic analysis: modeling using the SAAM computer programs. Foster DM; Boston RC; Jacquez JA; Zech L Health Phys; 1989; 57 Suppl 1():457-66. PubMed ID: 2606705 [TBL] [Abstract][Full Text] [Related]
60. Software for dynamic analysis of tracer-based metabolomic data: estimation of metabolic fluxes and their statistical analysis. Selivanov VA; Marin S; Lee PW; Cascante M Bioinformatics; 2006 Nov; 22(22):2806-12. PubMed ID: 17000750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]